Understanding how bacteria manage formaldehyde levels and repair damage
Formaldehyde homeostasis and damage repair in a bacterial formaldehyde specialist
This study is looking at how certain helpful bacteria deal with formaldehyde, a compound that can be both good and bad for us, to understand how they protect themselves, which might help us learn more about its effects on human health, especially for conditions like dementia and diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10872148 on NIH RePORTER |
What this research studies
This research investigates how certain bacteria, specifically methylotrophic bacteria, manage formaldehyde, a naturally occurring compound that can be both harmful and beneficial. The study focuses on two key proteins, EfgA and TtmR, which help these bacteria sense and respond to formaldehyde levels, preventing cellular damage. By using advanced sequencing techniques and experimental evolution, the researchers aim to uncover the mechanisms behind formaldehyde homeostasis and stress responses in these organisms. This knowledge could provide insights into how similar processes might affect human health, particularly in relation to diseases like dementia and diabetes.
Who could benefit from this research
Good fit: Ideal candidates for potential benefit from this research include individuals affected by dementia or diabetes, as well as those interested in the biological mechanisms of formaldehyde in human health.
Not a fit: Patients with conditions unrelated to formaldehyde exposure or metabolism may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for managing diseases associated with formaldehyde, such as dementia and diabetes.
How similar studies have performed: While the specific mechanisms being studied are novel, previous research has shown that understanding cellular responses to harmful metabolites can lead to significant advancements in treating related diseases.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Bazurto, Jannell V. — University of Minnesota
- Study coordinator: Bazurto, Jannell V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.